Strategic Advocates »

Fs Global Cr Opportunitie Fda shares owned by Strategic Advocates

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Strategic Advocates from 13F filings

Historical chart of Strategic Advocates investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Strategic Advocates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Strategic Advocates

Quarter filed Position value Share count Share price at filing
2025-09-30 $229k 33k 6.91
2025-06-30 $240k 33k 7.26
2025-03-31 $234k 33k 7.05
2024-12-31 $226k 33k 6.82
2024-09-30 $210k 33k 6.35
2024-06-30 $211k 33k 6.37
2024-03-31 $196k 33k 5.93
2023-12-31 $209k 37k 5.67

More positions owned by Strategic Advocates

State Street Spdr S&p Kensho New Economies Composite Etf Etf (KOMP)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Invesco S&p 500 Pure Value Etf Etf (RPV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
State Street Spdr Portfolio Long Term Corporate Bond Etf Etf (SPLB)
Vanguard S&p Small-cap 600 Growth Etf Etf (VIOG)
Ishares 1-5 Year Investment Grade Corporate Bond Etf Etf (IGSB)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Palantir Technologies Inc Cl A Stock (PLTR)
Tesla Stock (TSLA)
Pimco 0-5 Year High Yield Corporate Bond Index Exchange-traded Fund Etf (HYS)
Amazon Stock (AMZN)
Meta Platforms Inc Cl A Stock (META)

View all positions for Strategic Advocates

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Cambridge Investment Research Advisors
Cetera Investment Advisers
Sit Investment Associates
LPL Financial
Vista Finance
H D Vest Advisory Services
Blackstone Group
Rockefeller Capital Management
Advisor Group Holdings
Morgan Stanley
Summit Financial
Envestnet Asset Management
Thomas J. Herzfeld Advisors
Ellis Investment Partners

View all funds holding Fs Global Cr Opportunitie Fda